Birdwatch Note
2024-02-18 13:08:55 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
新型コロナワクチン接種後には軽症の心筋炎や適切な対処をすれば問題がないアナフィラキシー等の副反応が低確率で起きます https://www.cov19-vaccine.mhlw.go.jp/qa/0079.html https://www.cov19-vaccine.mhlw.go.jp/qa/0002.html しかし、後遺症を裏付ける科学的根拠はありません https://www.cov19-vaccine.mhlw.go.jp/qa/0170.html 世界中の研究で接種後の死亡リスクの有意な上昇も認められていません https://www.cov19-vaccine.mhlw.go.jp/qa/0081.html 厚生科学審議会 (予防接種・ワクチン分科会 副反応検討部会)においても、2千件以上の接種後死亡のうちα(因果関係が否定できない→シロではないとしているがクロかグレーかは評価していない)はわずか2件です https://www.mhlw.go.jp/stf/shingi/shingi-kousei_284075.html 不確かな噂に惑わされずに信頼できる情報源からの情報収集に努めましょう https://www.cov19-vaccine.mhlw.go.jp/qa/0075.html https://togetter.com/li/2195650 https://togetter.com/li/2176345 https://togetter.com/li/2174198
Written by 7A9FF9E0AC22B46DA9E28988C69E88AB84BA7BDC51EFDA1B44D021A9037A2442
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1759190587927077150
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1759203339974389994
- noteId - 1759203339974389994
- participantId -
- noteAuthorParticipantId - 7A9FF9E0AC22B46DA9E28988C69E88AB84BA7BDC51EFDA1B44D021A9037A2442 Participant Details
- createdAtMillis - 1708261735324
- tweetId - 1759190587927077150
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 1
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 新型コロナワクチン接種後には軽症の心筋炎や適切な対処をすれば問題がないアナフィラキシー等の副反応が低確率で起きます https://www.cov19-vaccine.mhlw.go.jp/qa/0079.html https://www.cov19-vaccine.mhlw.go.jp/qa/0002.html しかし、後遺症を裏付ける科学的根拠はありません https://www.cov19-vaccine.mhlw.go.jp/qa/0170.html 世界中の研究で接種後の死亡リスクの有意な上昇も認められていません https://www.cov19-vaccine.mhlw.go.jp/qa/0081.html 厚生科学審議会 (予防接種・ワクチン分科会 副反応検討部会)においても、2千件以上の接種後死亡のうちα(因果関係が否定できない→シロではないとしているがクロかグレーかは評価していない)はわずか2件です https://www.mhlw.go.jp/stf/shingi/shingi-kousei_284075.html 不確かな噂に惑わされずに信頼できる情報源からの情報収集に努めましょう https://www.cov19-vaccine.mhlw.go.jp/qa/0075.html https://togetter.com/li/2195650 https://togetter.com/li/2176345 https://togetter.com/li/2174198
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-02-18 13:08:55 UTC (1708261735324) |
2024-02-18 20:15:44 UTC (1708287344167) |
CURRENTLY_RATED_HELPFUL | 2024-02-19 09:04:13 UTC (1708333453151) |
CURRENTLY_RATED_HELPFUL | 2024-02-18 20:15:44 UTC (1708287344167) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-02-19 00:52:03 -0600 | Rating Details | |
2024-02-19 00:16:32 -0600 | Rating Details | |
2024-02-18 23:47:52 -0600 | Rating Details | |
2024-02-18 22:35:24 -0600 | Rating Details | |
2024-02-18 15:46:02 -0600 | Rating Details | |
2024-02-18 11:53:31 -0600 | Rating Details | |
2024-02-18 11:06:23 -0600 | Rating Details | |
2024-02-18 10:58:26 -0600 | Rating Details | |
2024-02-18 10:25:05 -0600 | Rating Details | |
2024-02-18 08:46:24 -0600 | Rating Details | |
2024-02-18 08:29:31 -0600 | Rating Details | |
2024-02-18 08:25:50 -0600 | Rating Details | |
2024-02-18 08:25:09 -0600 | Rating Details | |
2024-02-18 08:02:11 -0600 | Rating Details | |
2024-02-18 07:12:44 -0600 | Rating Details | |
2024-02-19 05:26:28 -0600 | Rating Details | |
2024-02-20 07:53:32 -0600 | Rating Details | |
2024-02-19 04:42:38 -0600 | Rating Details | |
2024-02-19 01:50:10 -0600 | Rating Details | |
2024-02-18 12:31:15 -0600 | Rating Details | |
2024-02-18 10:33:52 -0600 | Rating Details | |
2024-02-18 09:54:58 -0600 | Rating Details | |
2024-02-18 09:38:40 -0600 | Rating Details | |
2024-02-18 08:57:45 -0600 | Rating Details | |
2024-02-18 08:54:28 -0600 | Rating Details | |
2024-02-18 08:38:19 -0600 | Rating Details | |
2024-02-18 08:34:03 -0600 | Rating Details | |
2024-02-18 07:38:11 -0600 | Rating Details | |
2024-02-23 00:48:10 -0600 | Rating Details |